{
    "title": "U.S. FDA grants appeal for Ardelyx's kidney disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11582415/U-S-FDA-grants-appeal-Ardelyxs-kidney-disease-drug.html",
    "date": "2022-12-29",
    "keywords": [
        "drug",
        "appeal",
        "year",
        "company",
        "tenapanor",
        "health",
        "regulator",
        "month",
        "meeting",
        "approval",
        "phosphate",
        "dec",
        "food",
        "administration",
        "agency",
        "kidney",
        "disease",
        "thursday",
        "news",
        "ardelyxs",
        "premarket",
        "trade",
        "marketing",
        "application",
        "half",
        "decision",
        "committee",
        "fda",
        "therapy",
        "blood",
        "dialysis",
        "efficacy",
        "panel",
        "level",
        "body",
        "pathway",
        "brand",
        "name",
        "ibsrela",
        "canada",
        "treatment",
        "bowel",
        "syndrome",
        "ardelyx",
        "plc",
        "pratik",
        "jain",
        "khushi",
        "mandowara",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}